Nicotine therapeutic benefits: Difference between revisions
| (One intermediate revision by the same user not shown) | |||
| Line 1,876: | Line 1,876: | ||
='''Suggested additions to this page'''= | ='''Suggested additions to this page'''= | ||
===2925: [https://link.springer.com/article/10.1186/s12890-025-04071-4 Modulatory roles of the vagus nerve and nicotine in bleomycin-induced pulmonary fibrosis in rats]=== | |||
===2021: [https://link.springer.com/article/10.1007/s12640-021-00375-5 Novel Pharmacotherapies in Parkinson’s Disease]=== | ===2021: [https://link.springer.com/article/10.1007/s12640-021-00375-5 Novel Pharmacotherapies in Parkinson’s Disease]=== | ||
| Line 1,888: | Line 1,890: | ||
===2019: [https://medium.com/parkinsons-uk/protecting-brain-cells-the-story-of-nicotine-b3b51f5b8259 Protecting brain cells — the story of nicotine]=== | ===2019: [https://medium.com/parkinsons-uk/protecting-brain-cells-the-story-of-nicotine-b3b51f5b8259 Protecting brain cells — the story of nicotine]=== | ||
*[https://web.archive.org/web/20221021040501/https://www.parkinsons.org.uk/nicotine-good-bad-and-ugly Nicotine - Good, Bad, Ugly] | *[https://web.archive.org/web/20221021040501/https://www.parkinsons.org.uk/nicotine-good-bad-and-ugly Nicotine - Good, Bad, Ugly] | ||
===2018: [https://pubmed.ncbi.nlm.nih.gov/29770521/ Nicotine-mediated neuroprotection of rat spinal networks against excitotoxicity]=== | |||
===2017 [https://www.ncbi.nlm.nih.gov/pubmed/27940486 Moist smokeless tobacco (Snus) use and risk of Parkinson's disease]=== | ===2017 [https://www.ncbi.nlm.nih.gov/pubmed/27940486 Moist smokeless tobacco (Snus) use and risk of Parkinson's disease]=== | ||